Formulation and Delivery

Co-processing technologies to Simplify Your Oral Solid Dosage (OSD) Formulation Process

Partner Presentation Speaker(s)

• 

  San Kiang, Ph.D.

  CTO, Drug Product R&D
  Porton, J-Star
  Cranbury Township, New Jersey

Description: Co-processing is a technology platform that physically combines API and one or two commonly used excipients before, during or after crystallization. While crystallization and particle engineering are commonly used technologies to modify the morphology of the API, there are limitations to the extent of improvement.

Often, co-processing can overcome these limitations in a shorter time. From a scale-up and manufacturing point of view, co-processing technologies use the same equipment train as in crystallization. The importance of co-processing has increasingly been noticed by the pharmaceutical industry and the FDA to the extent that more than 10 pharma companies have formed a technology consortium to improve communications with the Health Authorities (HA’s). In return, the FDA has conducted one workshop to facilitate the adoption of the technology. This talk aims to bring awareness of co-processing technology to a wider audience.